Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 310.00
Bid: 307.00
Ask: 312.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.629%)
Open: 311.00
High: 314.00
Low: 303.00
Prev. Close: 310.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Cordiant deploys IPO funds; Scotgold gets loan

Tue, 04th May 2021 20:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Cordiant Digital Infrastructure Ltd - investment firm focused on digital infrastructure assets - Announces deployment or commitment of substantially all of the net proceeds from its IPO into digital infrastructure platforms in the Czech Republic and Norway. Company has completed the acquisition of Ceske Radiokomunikace and entered into a legally binding letter of intent to acquire a Norwegian fibre network and certain land for data centre development for a combined total consideration of GBP451 million, comprising GBP318 million of equity and the assumption of an amount equal to GBP133 million of debt. Adds it has raised its dividend guidance, now targeting "no less than 3 pence per share" for the current financial year, up from 1p. Firm floated in London in February.

----------

Hutchmed (China) Ltd - Hong-Kong-based pharmaceutical company - Completes rolling submission of a new drug application to the US FDA for surufatinib for the treatment of pancreatic and extra-pancreatic neuroendocrine tumors. "Having successfully launched surufatinib in China early this year, we are now looking forward, subject to its approval, to being able to provide access to this important new therapeutic option for NETs patients in the US and beyond," says Marek Kania, managing director & chief medical officer of Hutchmed International Corp.

----------

AfriTin Mining Ltd - tin miner with asset in Namibia - Says definitive feasibility study confirms the feasibility of expanding the current phase 1 processing plant, resulting in a 67% increase in tin concentrate production to 1,200 tonnes per year from 720 tonnes. "The DFS confirms the highly attractive economics from a low-cost modular expansion of the current phase 1 at Uis which can be implemented in eight months. The DFS also coincides with the company achieving its first full quarter of steady state production at the phase 1 plant as a global tin prices reach a 10-year high," says Chief Executive Anthony Viljoen.

----------

SDX Energy PLC - London-headquartered oil and gas exploration, production, and development company - Starts the first phase of its 2021 drilling campaign in Morocco, which will comprise up to five wells over the year. The first phase will consist of three appraisal/development wells. The second phase of the Moroccan drilling campaign will commence in the autumn.

----------

Intelligent Ultrasound Group PLC - Cardiff, Wales-based artificial intelligence ultrasound software firm - Successfully registers with the MHRA to market ScanNav Anatomy: Peripheral Nerve Block in the UK and will be launching the product into the UK market at the forthcoming RA-UK annual scientific meeting. Continues to progress regulatory filing with US Food & Drug Administration, as well as seeking to licence an integrated version of the product to major ultrasound manufacturers. "ScanNav PNB uses the latest AI technology to automatically highlight the live ultrasound image to enhance the accuracy and standardisation of ultrasound image interpretation, by making it easier to identify key anatomical structures," company explains.

----------

CAP-XX Ltd - Australia-based supercapacitors and energy management systems manufacturer - Says Jack, developer of the first windshield breakage detection solution, has selected the CAP-XX HS208F supercap for its solar-powered Internet-of-Things device. "We are proud to provide the high energy and power density Jack needs to power its advanced communication system," said Anthony Kongats, chief executive at CAP-XX. "This is just one of the many possible applications for thin CAP-XX supercapacitors in IoT devices."

----------

Panther Metals PLC - company focused on mineral exploration in Canada and Australia - Receives new exploration permit to proceed with the revised plans for reconnaissance diamond drilling, ground induced polarisation geophysics and trenching focussed on testing intrusive contact shear-zone hosted gold mineralisation in the vicinity of the north shore of Dotted Lake. The new permit will allow Panther to drill up to 8 diamond drill holes this season where initial results warrant. The new permit extends these exploration permissions for three years to April 26, 2024. "This receipt now facilitates us to move our revised plans forward and we are currently engaging with potential contractors with a view to drill at the earliest opportunity," says Chief Executive Darren Hazelwood.

----------

Tribal Group PLC - provider of education software and services - Has acquired and paid for the remaining issued share capital of Semestry Limited, a supplier of cloud based scheduling and timetabling software to the higher education market. "Semestry has traded in line with expectations since the acquisition and the integration is progressing to plan," says Tribal.

----------

Secured Income Fund PLC - investor focused on SME loan assets and secured lending opportunities - Will return GBP3.7 million to shareholders via a second return of capital by the issue of B shares. Proceeds from the redemption of the B shares is equivalent to 7.0p per ordinary share, firm says. Capital being returned represents around 11% of company's net asset value as at end of March.

----------

Power Metal Resources PLC - metal exploration and development company - Establishes new 100%-owned and subsidiary 'incubator' business, Power Capital Investments Ltd, which will be initially be fully funded by the company. "Power Capital will actively identify small, entrepreneurial business ventures with significant growth potential in the junior resource space and provide support with regard to business management, project development and corporate development to enable them to scale rapidly and realise their potential. Power Capital may also provide financial support," Power Metal Resources explains.

----------

Scotgold Resources Ltd - gold exploration and production company focused on Scotland - Gets short-term loan of GBP2 million from group comprising Non-Executive Chair Nathaniel le Roux; non-executive directors Bill Styslinger, Peter Hetherington and Ian Proctor; and an unrelated third party. Loan provided to SGZ Cononish Ltd, a wholly-owned subsidiary of Scotgold.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 Jul 2022 13:20

IN BRIEF: Hutchmed starts phase I trial of HMPL-A83

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Begins phase I trial of HMPL-A83 for patients with advanced malignant neoplasms, in China. HMPL-A83 is an investigational novel IgG4-type humanized anti-CD47 monoclonal antibody. Malignant neoplasms are cancerous tumours. It has "significant" potential to be used as a combination therapy with Hutchmed's existing portfolio, the firm says.

Read more
13 Jul 2022 09:35

IN BRIEF: Hutchmed presents solid results from lung cancer study

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Presents positive results from the Savannah phase two trial of Hutchmed and AstraZeneca PLC's savolitinib in combination with Astra's osimertinib in epidermal growth factor receptor-mutated non-small cell lung cancer patients.

Read more
6 Jul 2022 10:37

AIM WINNERS & LOSERS: Hutchmed down amid China Covid woes; Parkmead up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
6 Jul 2022 09:25

Hutchmed phase I trial for IMG-007 doses first patient

(Alliance News) - Hutchmed China Ltd on Wednesday announced the first patient has been dosed for its phase I trial for IMG-007.

Read more
1 Jun 2022 10:07

IN BRIEF: Hutchmed China wins cancer drug Tazverik approval in Hainan

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Receives approval for Tazverik from the Health Commission & Medical Products Administration of the Hainan province in China. The approval is for use in the Hainan pilot zone under the Clinically Urgently Needed Imported Drugs scheme, for the treatment of certain patients with epithelioid sarcoma and follicular lymphoma.

Read more
3 May 2022 12:14

LONDON MARKET MIDDAY: Stocks down as aggressive US Fed rate hike looms

(Alliance News) - Stock prices in London were lower at midday on Tuesday following the long bank holiday weekend in the UK, as markets globally prepare for a sharp US interest rate hike and similar moves by other central banks as they struggle to control inflation.

Read more
3 May 2022 11:29

AIM WINNERS & LOSERS: Hutchmed sinks on US FDA drug rejection

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
3 May 2022 11:25

IN BRIEF: US FDA says Hutchmed's pancreatic drug needs more testing

Hutchmed (China) Ltd - Hong Kong-based biopharmaceuticals - The US Food & Drug Administration has rejected Hutchmed's surufatinib for treatment of pancreatic neuroendocrine tumours. In a complete response letter, the FDA says the current data package, based on two positive phase three trials in China and one bridging study in the US, does not support an approval in the US "at this time". The FDA said a multi-regional clinical trial of surufatinib required for US approval. Surufatinib was approved in China for the treatment of pNETs and extra-pancreatic neuroendocrine tumours in June 2021 and December 2020, respectively. Chief Executive Officer & Chief Scientific Officer Weiguo Su comments: "Although this decision from the FDA is disappointing, we remain confident about the clinical value of surufatinib for NET patients and committed to making surufatinib available to patients globally. We look forward to working with the agency to evaluate its feedback."

Read more
3 May 2022 08:57

LONDON MARKET OPEN: BP rises despite taking hit from Rosneft exit

(Alliance News) - Stock prices in London opened lower on Tuesday following the long bank holiday weekend, with BP shares rising as the oil major planned to return cash to shareholders amid calls by some UK politicians for a windfall profit tax on energy companies.

Read more
3 May 2022 07:53

LONDON MARKET PRE-OPEN: BP swings to quarterly loss after Rosneft exit

(Alliance News) - Stock prices in London are seen opening lower on Tuesday, after the long bank holiday weekend in the UK, as concerns rise over aggressive monetary policy tightening by the US Federal Reserve.

Read more
25 Apr 2022 10:45

AIM WINNERS & LOSERS: musicMagpie sells on new platform; Hutchmed down

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Apr 2022 16:05

UK shareholder meetings calendar - next 7 days

Thursday 21 April 
Alliance Trust PLCAGM
Ibstock PLCAGM
Journeo PLCAGM
Relx PLCAGM
STV Group PLCAGM
Ruffer Investment Co LtdEGM re share issue
Friday 22 April 
Bellevue Healthcare Trust PLCAGM
Faron Pharmaceuticals LtdAGM
Murray International Trust PLCAGM
Monday 25 April 
Belluscura PLCAGM
Capital Gearing Trust PLCGM re non pre-emptive share issue
Cloudbreak Discovery PLCGM re Crescita equity drawdown agreement
Hikma Pharmaceuticals PLCAGM
JPMorgan US Smaller Cos Investment Trust PLCAGM
Polymetal International PLCAGM
Symphony International Holdings LtdAGM
Tuesday 26 April 
Aquis Exchange PLCAGM
Elementis PLCAGM
GlobalData PLCAGM
Oriole Resources PLCAGM
RPS Group PLCAGM
SigmaRoc PLCAGM
Taylor Wimpey PLCAGM
Tissue Regenix Group PLCAGM
Wednesday 27 April 
Drax Group PLCAGM
EP Global Opportunities Trust PLCAGM
Global Invacom Group LtdAGM
Hutchmed (China) LtdAGM
London Stock Exchange Group PLCAGM
McKay Securities PLCGM re Workspace offer
Nichols PLCAGM
Persimmon PLCAGM
Primary Health Properties PLCAGM
VH Global Sustainable Energy Opportunities PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
31 Mar 2022 10:43

IN BRIEF: Hutchmed China named by SEC, might delist Nasdaq shares

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - US Securities & Exchange Commission identifies Hutchmed China under the new Holding Foreign Companies Accountable Act, which identifies public companies who have used auditors from overseas or auditors who are unable to be investigated completely. The new regulation has no impact on business operations, Hutchmed says.

Read more
31 Mar 2022 10:04

Hutchmed China confident after being added to SEC list

(Sharecast News) - Hutchmed China updated the market on its status under the United States 'Holding Foreign Companies Accountable Act' on Thursday.

Read more
11 Mar 2022 11:15

AIM WINNERS & LOSERS: Omega Diagnostics Visitect not available in UK

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.